Medical Devices

Global Xerophthalmia Treatment Market Size, Status and Forecast 2018-2025

  • QYR2795428
  • 106 Pages
  • October 2018
  • Medical Devices
Download Sample    Get Discount   
 
In 2017, the global Xerophthalmia Treatment market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2018-2025.

This report focuses on the global Xerophthalmia Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Xerophthalmia Treatment development in United States, Europe and China.

The key players covered in this study

Allergan Plc

Novartis AG

Otsuka Pharmaceutical Co.,Ltd.

Abbott Laboratories

Santen Pharmaceutical Co Ltd

Valent Pharmaceuticals

Akorn, Inc

Shire Plc

Thea Pharmaceuticals Limited

OASIS Medical

Altaire Pharmaceuticals Inc

Boiron USA

Similasan Corporation

Scope Ophthalmics Ltd.

Reckitt Benckiser Group PLC

Medicom Healthcare Ltd

FDC Limited

Lupin Limited

Jamjoom Pharmaceuticals Co.

Sentiss Pharma Private limited

Market segment by Type, the product can be split into

Cyclosporin

Oral Corticosteroids

Artificial Tears

Punctal Plugs

Omega Supplements

Others

Market segment by Application, split into

Hospital Pharmacies

Eye Health Clinics

Retail Pharmacies

Online Pharmacies

Market segment by Regions/Countries, this report covers

United States

Europe

China

Japan

Southeast Asia

India

Central & South America

The study objectives of this report are:

To analyze global Xerophthalmia Treatment status, future forecast, growth opportunity, key market and key players.

To present the Xerophthalmia Treatment development in United States, Europe and China.

To strategically profile the key players and comprehensively analyze their development plan and strategies.

To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Xerophthalmia Treatment are as follows:

History Year: 2013-2017

Base Year: 2017

Estimated Year: 2018

Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview

1.1 Study Scope

1.2 Key Market Segments

1.3 Players Covered

1.4 Market Analysis by Type

1.4.1 Global Xerophthalmia Treatment Market Size Growth Rate by Type (2013-2025)

1.4.2 Cyclosporin

1.4.3 Oral Corticosteroids

1.4.4 Artificial Tears

1.4.5 Punctal Plugs

1.4.6 Omega Supplements

1.4.7 Others

1.5 Market by Application

1.5.1 Global Xerophthalmia Treatment Market Share by Application (2013-2025)

1.5.2 Hospital Pharmacies

1.5.3 Eye Health Clinics

1.5.4 Retail Pharmacies

1.5.5 Online Pharmacies

1.6 Study Objectives

1.7 Years Considered

2 Global Growth Trends

2.1 Xerophthalmia Treatment Market Size

2.2 Xerophthalmia Treatment Growth Trends by Regions

2.2.1 Xerophthalmia Treatment Market Size by Regions (2013-2025)

2.2.2 Xerophthalmia Treatment Market Share by Regions (2013-2018)

2.3 Industry Trends

2.3.1 Market Top Trends

2.3.2 Market Drivers

2.3.3 Market Opportunities

3 Market Share by Key Players

3.1 Xerophthalmia Treatment Market Size by Manufacturers

3.1.1 Global Xerophthalmia Treatment Revenue by Manufacturers (2013-2018)

3.1.2 Global Xerophthalmia Treatment Revenue Market Share by Manufacturers (2013-2018)

3.1.3 Global Xerophthalmia Treatment Market Concentration Ratio (CR5 and HHI)

3.2 Xerophthalmia Treatment Key Players Head office and Area Served

3.3 Key Players Xerophthalmia Treatment Product/Solution/Service

3.4 Date of Enter into Xerophthalmia Treatment Market

3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

4.1 Global Xerophthalmia Treatment Market Size by Type (2013-2018)

4.2 Global Xerophthalmia Treatment Market Size by Application (2013-2018)

5 United States

5.1 United States Xerophthalmia Treatment Market Size (2013-2018)

5.2 Xerophthalmia Treatment Key Players in United States

5.3 United States Xerophthalmia Treatment Market Size by Type

5.4 United States Xerophthalmia Treatment Market Size by Application

6 Europe

6.1 Europe Xerophthalmia Treatment Market Size (2013-2018)

6.2 Xerophthalmia Treatment Key Players in Europe

6.3 Europe Xerophthalmia Treatment Market Size by Type

6.4 Europe Xerophthalmia Treatment Market Size by Application

7 China

7.1 China Xerophthalmia Treatment Market Size (2013-2018)

7.2 Xerophthalmia Treatment Key Players in China

7.3 China Xerophthalmia Treatment Market Size by Type

7.4 China Xerophthalmia Treatment Market Size by Application

8 Japan

8.1 Japan Xerophthalmia Treatment Market Size (2013-2018)

8.2 Xerophthalmia Treatment Key Players in Japan

8.3 Japan Xerophthalmia Treatment Market Size by Type

8.4 Japan Xerophthalmia Treatment Market Size by Application

9 Southeast Asia

9.1 Southeast Asia Xerophthalmia Treatment Market Size (2013-2018)

9.2 Xerophthalmia Treatment Key Players in Southeast Asia

9.3 Southeast Asia Xerophthalmia Treatment Market Size by Type

9.4 Southeast Asia Xerophthalmia Treatment Market Size by Application

10 India

10.1 India Xerophthalmia Treatment Market Size (2013-2018)

10.2 Xerophthalmia Treatment Key Players in India

10.3 India Xerophthalmia Treatment Market Size by Type

10.4 India Xerophthalmia Treatment Market Size by Application

11 Central & South America

11.1 Central & South America Xerophthalmia Treatment Market Size (2013-2018)

11.2 Xerophthalmia Treatment Key Players in Central & South America

11.3 Central & South America Xerophthalmia Treatment Market Size by Type

11.4 Central & South America Xerophthalmia Treatment Market Size by Application

12 International Players Profiles

12.1 Allergan Plc

12.1.1 Allergan Plc Company Details

12.1.2 Company Description and Business Overview

12.1.3 Xerophthalmia Treatment Introduction

12.1.4 Allergan Plc Revenue in Xerophthalmia Treatment Business (2013-2018)

12.1.5 Allergan Plc Recent Development

12.2 Novartis AG

12.2.1 Novartis AG Company Details

12.2.2 Company Description and Business Overview

12.2.3 Xerophthalmia Treatment Introduction

12.2.4 Novartis AG Revenue in Xerophthalmia Treatment Business (2013-2018)

12.2.5 Novartis AG Recent Development

12.3 Otsuka Pharmaceutical Co.,Ltd.

12.3.1 Otsuka Pharmaceutical Co.,Ltd. Company Details

12.3.2 Company Description and Business Overview

12.3.3 Xerophthalmia Treatment Introduction

12.3.4 Otsuka Pharmaceutical Co.,Ltd. Revenue in Xerophthalmia Treatment Business (2013-2018)

12.3.5 Otsuka Pharmaceutical Co.,Ltd. Recent Development

12.4 Abbott Laboratories

12.4.1 Abbott Laboratories Company Details

12.4.2 Company Description and Business Overview

12.4.3 Xerophthalmia Treatment Introduction

12.4.4 Abbott Laboratories Revenue in Xerophthalmia Treatment Business (2013-2018)

12.4.5 Abbott Laboratories Recent Development

12.5 Santen Pharmaceutical Co Ltd

12.5.1 Santen Pharmaceutical Co Ltd Company Details

12.5.2 Company Description and Business Overview

12.5.3 Xerophthalmia Treatment Introduction

12.5.4 Santen Pharmaceutical Co Ltd Revenue in Xerophthalmia Treatment Business (2013-2018)

12.5.5 Santen Pharmaceutical Co Ltd Recent Development

12.6 Valent Pharmaceuticals

12.6.1 Valent Pharmaceuticals Company Details

12.6.2 Company Description and Business Overview

12.6.3 Xerophthalmia Treatment Introduction

12.6.4 Valent Pharmaceuticals Revenue in Xerophthalmia Treatment Business (2013-2018)

12.6.5 Valent Pharmaceuticals Recent Development

12.7 Akorn, Inc

12.7.1 Akorn, Inc Company Details

12.7.2 Company Description and Business Overview

12.7.3 Xerophthalmia Treatment Introduction

12.7.4 Akorn, Inc Revenue in Xerophthalmia Treatment Business (2013-2018)

12.7.5 Akorn, Inc Recent Development

12.8 Shire Plc

12.8.1 Shire Plc Company Details

12.8.2 Company Description and Business Overview

12.8.3 Xerophthalmia Treatment Introduction

12.8.4 Shire Plc Revenue in Xerophthalmia Treatment Business (2013-2018)

12.8.5 Shire Plc Recent Development

12.9 Thea Pharmaceuticals Limited

12.9.1 Thea Pharmaceuticals Limited Company Details

12.9.2 Company Description and Business Overview

12.9.3 Xerophthalmia Treatment Introduction

12.9.4 Thea Pharmaceuticals Limited Revenue in Xerophthalmia Treatment Business (2013-2018)

12.9.5 Thea Pharmaceuticals Limited Recent Development

12.10 OASIS Medical

12.10.1 OASIS Medical Company Details

12.10.2 Company Description and Business Overview

12.10.3 Xerophthalmia Treatment Introduction

12.10.4 OASIS Medical Revenue in Xerophthalmia Treatment Business (2013-2018)

12.10.5 OASIS Medical Recent Development

12.11 Altaire Pharmaceuticals Inc

12.12 Boiron USA

12.13 Similasan Corporation

12.14 Scope Ophthalmics Ltd.

12.15 Reckitt Benckiser Group PLC

12.16 Medicom Healthcare Ltd

12.17 FDC Limited

12.18 Lupin Limited

12.19 Jamjoom Pharmaceuticals Co.

12.20 Sentiss Pharma Private limited

13 Market Forecast 2018-2025

13.1 Market Size Forecast by Regions

13.2 United States

13.3 Europe

13.4 China

13.5 Japan

13.6 Southeast Asia

13.7 India

13.8 Central & South America

13.9 Market Size Forecast by Product (2018-2025)

13.10 Market Size Forecast by Application (2018-2025)

14 Analyst\'s Viewpoints/Conclusions

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.1.1 Research Programs/Design

15.1.1.2 Market Size Estimation

12.1.1.3 Market Breakdown and Data Triangulation

15.1.2 Data Source

15.1.2.1 Secondary Sources

15.1.2.2 Primary Sources

15.2 Disclaimer

15.3 Author Details

List of Tables and Figures

Table Xerophthalmia Treatment Key Market Segments

Table Key Players Xerophthalmia Treatment Covered

Table Global Xerophthalmia Treatment Market Size Growth Rate by Type 2013-2025 (Million US$)

Figure Global Xerophthalmia Treatment Market Size Market Share by Type 2013-2025

Figure Cyclosporin Figures

Table Key Players of Cyclosporin

Figure Oral Corticosteroids Figures

Table Key Players of Oral Corticosteroids

Figure Artificial Tears Figures

Table Key Players of Artificial Tears

Figure Punctal Plugs Figures

Table Key Players of Punctal Plugs

Figure Omega Supplements Figures

Table Key Players of Omega Supplements

Figure Others Figures

Table Key Players of Others

Table Global Xerophthalmia Treatment Market Size Growth by Application 2013-2025 (Million US$)

Figure Hospital Pharmacies Case Studies

Figure Eye Health Clinics Case Studies

Figure Retail Pharmacies Case Studies

Figure Online Pharmacies Case Studies

Figure Xerophthalmia Treatment Report Years Considered

Table Global Xerophthalmia Treatment Market Size 2013-2025 (Million US$)

Figure Global Xerophthalmia Treatment Market Size and Growth Rate 2013-2025 (Million US$)

Table Global Xerophthalmia Treatment Market Size by Regions 2013-2025 (Million US$)

Table Global Xerophthalmia Treatment Market Size by Regions 2013-2018 (Million US$)

Table Global Xerophthalmia Treatment Market Share by Regions 2013-2018

Figure Global Xerophthalmia Treatment Market Share by Regions 2013-2018

Figure Global Xerophthalmia Treatment Market Share by Regions 2018

Table Market Top Trends

Table Global Xerophthalmia Treatment Revenue by Manufacturers (2013-2018) (Million US$)

Table Global Xerophthalmia Treatment Market Share by Manufacturers (2013-2018)

Figure Global Xerophthalmia Treatment Market Share by Manufacturers in 2018

Table Global Xerophthalmia Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)

Table Key Players Head office and Area Served

Table Key Players Xerophthalmia Treatment Product/Solution/Service

Table Date of Enter into Xerophthalmia Treatment Market

Table Mergers & Acquisitions, Expansion Plans

Table Global Xerophthalmia Treatment Market Size by Type (2013-2018) (Million US$)

Table Global Xerophthalmia Treatment Market Size Share by Type (2013-2018)

Figure Global Xerophthalmia Treatment Market Size Market Share by Type (2013-2018)

Table Global Xerophthalmia Treatment Market Size by Application (2013-2018) (Million US$)

Table Global Xerophthalmia Treatment Market Size Share by Application (2013-2018)

Figure Global Xerophthalmia Treatment Market Size Market Share by Application (2013-2018)

Figure Global Xerophthalmia Treatment Revenue Market Share by Application in 2017

Figure United States Xerophthalmia Treatment Market Size 2013-2018 (Million US$)

Table United States Key Players Xerophthalmia Treatment Revenue (2017-2018) (Million US$)

Table United States Key Players Xerophthalmia Treatment Market Share (2017-2018)

Table United States Xerophthalmia Treatment Market Size by Type (2013-2018) (Million US$)

Table United States Xerophthalmia Treatment Market Share by Type (2013-2018)

Table United States Xerophthalmia Treatment Market Size by Application (2013-2018) (Million US$)

Table United States Xerophthalmia Treatment Market Share by Application (2013-2018)

Figure Europe Xerophthalmia Treatment Market Size 2013-2018 (Million US$)

Table Europe Key Players Xerophthalmia Treatment Revenue (2017-2018) (Million US$)

Table Europe Key Players Xerophthalmia Treatment Market Share (2017-2018)

Table Europe Xerophthalmia Treatment Market Size by Type (2013-2018) (Million US$)

Table Europe Xerophthalmia Treatment Market Share by Type (2013-2018)

Table Europe Xerophthalmia Treatment Market Size by Application (2013-2018) (Million US$)

Table Europe Xerophthalmia Treatment Market Share by Application (2013-2018)

Figure China Xerophthalmia Treatment Market Size 2013-2018 (Million US$)

Table China Key Players Xerophthalmia Treatment Revenue (2017-2018) (Million US$)

Table China Key Players Xerophthalmia Treatment Market Share (2017-2018)

Table China Xerophthalmia Treatment Market Size by Type (2013-2018) (Million US$)

Table China Xerophthalmia Treatment Market Share by Type (2013-2018)

Table China Xerophthalmia Treatment Market Size by Application (2013-2018) (Million US$)

Table China Xerophthalmia Treatment Market Share by Application (2013-2018)

Figure Japan Xerophthalmia Treatment Market Size 2013-2018 (Million US$)

Table Japan Key Players Xerophthalmia Treatment Revenue (2017-2018) (Million US$)

Table Japan Key Players Xerophthalmia Treatment Market Share (2017-2018)

Table Japan Xerophthalmia Treatment Market Size by Type (2013-2018) (Million US$)

Table Japan Xerophthalmia Treatment Market Share by Type (2013-2018)

Table Japan Xerophthalmia Treatment Market Size by Application (2013-2018) (Million US$)

Table Japan Xerophthalmia Treatment Market Share by Application (2013-2018)

Figure Southeast Asia Xerophthalmia Treatment Market Size 2013-2018 (Million US$)

Table Southeast Asia Key Players Xerophthalmia Treatment Revenue (2017-2018) (Million US$)

Table Southeast Asia Key Players Xerophthalmia Treatment Market Share (2017-2018)

Table Southeast Asia Xerophthalmia Treatment Market Size by Type (2013-2018) (Million US$)

Table Southeast Asia Xerophthalmia Treatment Market Share by Type (2013-2018)

Table Southeast Asia Xerophthalmia Treatment Market Size by Application (2013-2018) (Million US$)

Table Southeast Asia Xerophthalmia Treatment Market Share by Application (2013-2018)

Figure India Xerophthalmia Treatment Market Size 2013-2018 (Million US$)

Table India Key Players Xerophthalmia Treatment Revenue (2017-2018) (Million US$)

Table India Key Players Xerophthalmia Treatment Market Share (2017-2018)

Table India Xerophthalmia Treatment Market Size by Type (2013-2018) (Million US$)

Table India Xerophthalmia Treatment Market Share by Type (2013-2018)

Table India Xerophthalmia Treatment Market Size by Application (2013-2018) (Million US$)

Table India Xerophthalmia Treatment Market Share by Application (2013-2018)

Figure Central & South America Xerophthalmia Treatment Market Size 2013-2018 (Million US$)

Table Central & South America Key Players Xerophthalmia Treatment Revenue (2017-2018) (Million US$)

Table Central & South America Key Players Xerophthalmia Treatment Market Share (2017-2018)

Table Central & South America Xerophthalmia Treatment Market Size by Type (2013-2018) (Million US$)

Table Central & South America Xerophthalmia Treatment Market Share by Type (2013-2018)

Table Central & South America Xerophthalmia Treatment Market Size by Application (2013-2018) (Million US$)

Table Central & South America Xerophthalmia Treatment Market Share by Application (2013-2018)

Table Allergan Plc Company Details

Table Allergan Plc Revenue in Xerophthalmia Treatment Business (2013-2018) (Million US$)

Figure Allergan Plc Revenue Growth Rate in Xerophthalmia Treatment Business (2013-2018)

Table Allergan Plc Recent Development

Table Novartis AG Company Details

Table Novartis AG Revenue in Xerophthalmia Treatment Business (2013-2018)(Million US$)

Figure Novartis AG Revenue Growth Rate in Xerophthalmia Treatment Business (2013-2018)

Table Novartis AG Recent Development

Table Otsuka Pharmaceutical Co.,Ltd. Company Details

Table Otsuka Pharmaceutical Co.,Ltd. Revenue in Xerophthalmia Treatment Business (2013-2018)(Million US$)

Figure Otsuka Pharmaceutical Co.,Ltd. Revenue Growth Rate in Xerophthalmia Treatment Business (2013-2018)

Table Otsuka Pharmaceutical Co.,Ltd. Recent Development

Table Abbott Laboratories Company Details

Table Abbott Laboratories Revenue in Xerophthalmia Treatment Business (2013-2018)(Million US$)

Figure Abbott Laboratories Revenue Growth Rate in Xerophthalmia Treatment Business (2013-2018)

Table Abbott Laboratories Recent Development

Table Santen Pharmaceutical Co Ltd Company Details

Table Santen Pharmaceutical Co Ltd Revenue in Xerophthalmia Treatment Business (2013-2018)(Million US$)

Figure Santen Pharmaceutical Co Ltd Revenue Growth Rate in Xerophthalmia Treatment Business (2013-2018)

Table Santen Pharmaceutical Co Ltd Recent Development

Table Valent Pharmaceuticals Company Details

Table Valent Pharmaceuticals Revenue in Xerophthalmia Treatment Business (2013-2018)(Million US$)

Figure Valent Pharmaceuticals Revenue Growth Rate in Xerophthalmia Treatment Business (2013-2018)

Table Valent Pharmaceuticals Recent Development

Table Akorn, Inc Company Details

Table Akorn, Inc Revenue in Xerophthalmia Treatment Business (2013-2018)(Million US$)

Figure Akorn, Inc Revenue Growth Rate in Xerophthalmia Treatment Business (2013-2018)

Table Akorn, Inc Recent Development

Table Shire Plc Company Details

Table Shire Plc Revenue in Xerophthalmia Treatment Business (2013-2018)(Million US$)

Figure Shire Plc Revenue Growth Rate in Xerophthalmia Treatment Business (2013-2018)

Table Shire Plc Recent Development

Table Thea Pharmaceuticals Limited Company Details

Table Thea Pharmaceuticals Limited Revenue in Xerophthalmia Treatment Business (2013-2018)(Million US$)

Figure Thea Pharmaceuticals Limited Revenue Growth Rate in Xerophthalmia Treatment Business (2013-2018)

Table Thea Pharmaceuticals Limited Recent Development

Table OASIS Medical Company Details

Table OASIS Medical Revenue in Xerophthalmia Treatment Business (2013-2018)(Million US$)

Figure OASIS Medical Revenue Growth Rate in Xerophthalmia Treatment Business (2013-2018)

Table OASIS Medical Recent Development

Table Altaire Pharmaceuticals Inc Company Details

Table Boiron USA Company Details

Table Similasan Corporation Company Details

Table Scope Ophthalmics Ltd. Company Details

Table Reckitt Benckiser Group PLC Company Details

Table Medicom Healthcare Ltd Company Details

Table FDC Limited Company Details

Table Lupin Limited Company Details

Table Jamjoom Pharmaceuticals Co. Company Details

Table Sentiss Pharma Private limited Company Details

Table Global Xerophthalmia Treatment Market Size by Regions (Million US$) 2018-2025

Figure Global Xerophthalmia Treatment Market Size Share by Regions (2018-2025)

Figure Global Xerophthalmia Treatment Market Size Share by Regions in 2025

Figure United States Xerophthalmia Treatment Market Size Forecast (2018-2025)(Million USD)

Figure Europe Xerophthalmia Treatment Market Size Forecast (2018-2025)(Million USD)

Figure China Xerophthalmia Treatment Market Size Forecast (2018-2025)(Million USD)

Figure Japan Xerophthalmia Treatment Market Size Forecast (2018-2025)(Million USD)

Figure Southeast Asia Xerophthalmia Treatment Market Size Forecast (2018-2025)(Million USD)

Figure India Xerophthalmia Treatment Market Size Forecast (2018-2025)(Million USD)

Figure Central & South America Xerophthalmia Treatment Market Size Forecast (2018-2025)(Million USD)

Table Global Xerophthalmia Treatment Market Size by Product (2018-2025) (Million US$)

Figure Global Xerophthalmia Treatment Market Size by Product (2018-2025)

Figure Global Xerophthalmia Treatment Market Size by Product in 2025

Table Global Xerophthalmia Treatment Market Size by Application (2018-2025) (Million US$)

Figure Global Xerophthalmia Treatment Market Size by Application (2018-2025)

Figure Global Xerophthalmia Treatment Market Size by Application in 2025

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Similar Reports

Medical Implants Market By Type (Orthopedic Implants, cardiac implants, Stents, Spinal Implants, Neurostimulators, dental implants, Breast Implants, facial Implants) and By Materials (Metallic, Ceramic, Polymers, Natural) - Global Opportunity Analysis and Industry Forecast, 2014 - 2022

Medical implants are permanent devices such as pacemakers or temporary devices such as fracture plates which are removed once their function is completed. These implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials...

  • Publish Date: August 21, 2016
  • $5370
Ostomy Drainage Bags Market by Type (Colostomy Bags, Ileostomy Bags, Urostomy Bags, Continent Urostomy Bags, and Continent Ileostomy Bags) - Global Opportunity Analysis and Industry Forecast, 2014-2022

Ostomy is a surgery wherein an artificial opening, known as stoma, is created from the colon in the human body to eliminate body wastes such as urine, mucus, and stools, which are collected in artificial bags called ostomy drainage bags. These plastic/rub...

  • Publish Date: December 1, 2016
  • $5370